Trial Profile
Real-world trends in Vedolizumab usage in Inflammatory Bowel Disease an VICTORY Consortium study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 10 Oct 2018 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2018
- 17 Jan 2018 New trial record